Vanda Pharmaceuticals Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | 88.1% | -21.1% | -20.4% |
| Jun 2017 | 88.2% | -4.6% | -3.6% |
| Sep 2017 | 88.0% | -11.9% | -11.0% |
| Dec 2017 | 88.2% | -4.9% | -4.2% |
| Mar 2018 | 88.7% | 5.6% | 7.0% |
| Jun 2018 | 88.1% | 8.3% | 9.7% |
| Sep 2018 | 88.9% | 12.7% | 14.6% |
| Dec 2018 | 88.6% | 17.3% | 19.5% |
| Mar 2019 | 88.5% | -4.4% | -1.3% |
| Jun 2019 | 88.6% | 16.8% | 19.5% |
| Sep 2019 | 88.0% | 18.1% | 168.8% |
| Dec 2019 | 89.2% | 7.0% | 6.9% |
| Mar 2020 | 90.4% | -0.2% | 0.8% |
| Jun 2020 | 90.0% | 14.7% | 14.0% |
| Sep 2020 | 89.6% | 12.8% | 9.9% |
| Dec 2020 | 90.0% | 15.4% | 12.1% |
| Mar 2021 | 90.4% | 16.5% | 13.8% |
| Jun 2021 | 90.3% | 18.2% | 14.2% |
| Sep 2021 | 90.3% | 15.4% | 11.1% |
| Dec 2021 | 90.8% | 12.7% | 10.4% |
| Mar 2022 | 90.6% | -12.7% | -10.7% |
| Jun 2022 | 90.6% | 5.4% | 4.0% |
| Sep 2022 | 90.3% | 6.0% | 5.0% |
| Dec 2022 | 90.3% | 10.3% | 10.6% |
| Mar 2023 | 92.4% | 3.2% | 5.2% |
| Jun 2023 | 92.4% | -6.2% | 3.3% |
| Sep 2023 | 92.1% | -15.4% | 0.4% |
| Dec 2023 | 92.4% | -15.7% | -5.3% |
| Mar 2024 | 92.8% | -19.5% | -8.7% |
| Jun 2024 | 94.6% | -20.1% | -9.0% |
| Sep 2024 | 94.6% | -23.1% | -11.2% |
| Dec 2024 | 95.1% | -19.3% | -9.2% |
| Mar 2025 | 93.0% | -82.0% | -58.9% |
| Jun 2025 | 94.8% | -73.2% | -51.7% |
| Sep 2025 | 94.7% | -55.6% | -40.1% |
| Dec 2025 | 93.3% | -70.5% | -246.8% |
| Mar 2026 | 93.9% | -97.1% | -93.9% |
| Jun 2026 | 93.0% | -126.3% | -123.7% |